Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN393227 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-ADAM Metallopeptidase Domain 9 (ADAM9) (AA 36-136) antibody
- Antibody type
- Monoclonal
- Description
- This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 36-136
- Isotype
- IgG
- Antibody clone number
- 3E6
- Vial size
- 100 μg
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Submitted references RNAi-mediated ADAM9 gene silencing inhibits metastasis of adenoid cystic carcinoma cells.
Increased expression of a disintegrin and metalloprotease-9 in hepatocellular carcinoma: implications for tumor progression and prognosis.
Gene expression analysis of drug-resistant MCF-7 cells: implications for relation to extracellular matrix proteins.
Inhibition of platelets and tumor cell adhesion by the disintegrin domain of human ADAM9 to collagen I under dynamic flow conditions.
Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein.
Xu Q, Liu X, Cai Y, Yu Y, Chen W
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2010 Jun;31(3):217-24
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2010 Jun;31(3):217-24
Increased expression of a disintegrin and metalloprotease-9 in hepatocellular carcinoma: implications for tumor progression and prognosis.
Tao K, Qian N, Tang Y, Ti Z, Song W, Cao D, Dou K
Japanese journal of clinical oncology 2010 Jul;40(7):645-51
Japanese journal of clinical oncology 2010 Jul;40(7):645-51
Gene expression analysis of drug-resistant MCF-7 cells: implications for relation to extracellular matrix proteins.
Işeri OD, Kars MD, Arpaci F, Gündüz U
Cancer chemotherapy and pharmacology 2010 Feb;65(3):447-55
Cancer chemotherapy and pharmacology 2010 Feb;65(3):447-55
Inhibition of platelets and tumor cell adhesion by the disintegrin domain of human ADAM9 to collagen I under dynamic flow conditions.
Cominetti MR, Martin AC, Ribeiro JU, Djaafri I, Fauvel-Lafève F, Crépin M, Selistre-de-Araujo HS
Biochimie 2009 Aug;91(8):1045-52
Biochimie 2009 Aug;91(8):1045-52
Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein.
Taylor DR, Parkin ET, Cocklin SL, Ault JR, Ashcroft AE, Turner AJ, Hooper NM
The Journal of biological chemistry 2009 Aug 21;284(34):22590-600
The Journal of biological chemistry 2009 Aug 21;284(34):22590-600
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
